AbCelex Technologies to Participate at Two Upcoming Conferences

TORONTO, ONTARIO February 21, 2012 | AbCelex Technologies Inc. announced today that the Company will be participating at two upcoming international conferences:

  • 10th Annual BioPartnering North America, February 26-28, 2012, Vancouver Convention Centre;
  • GLOBE 2012, 12th Biennial Conference & Trade Fair on Business & the Environment, March 14–16, 2012, Vancouver Convention Centre.

About AbCelex Technologies Inc.

AbCelex Technologies Inc. is a privately owned Canadian biotechnology company committed to the discovery and development of innovative technologies for the diagnosis and treatment of variety of illnesses including cancer and infectious diseases. Our current efforts are catered towards the development and commercialization of high avidity single domain antibody (sdAb)-based diagnostic and food safety products to help patients worldwide with the best care possible. For more information, visit

About BioPartnering North America (BPN)

BioPartnering North America 2012 (BPN) brings together senior executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up. Now in its 10th year of partnering & dealmaking, BPN is focusing on the Pacific Rim. The strategy is to build on close ties with industry leaders in the Pacific Rim to create a unique opportunity for the U.S., Canada, and Europe to meet leading life science companies from Asia.

About Globe

Having been around since 1990, GLOBE is known as the quintessential gathering of global senior business and government representatives who meet to network and to advance the issues at the nexus of global business and sustainability agendas.


For further information, please contact: